Institut Catala D'Oncologia

OrganisationROR

Trials

  • NCT03691311

    Early phase 1, Status unknown, 60 people, 1 Oct 2018

  • NCT03366480

    Collaborator, Phase 1/2, Completed, 103 people, 8 Dec 2017

  • NCT01531712

    Phase 2, Terminated, 6 people, 13 Feb 2012

Grants and prizes

  • European Commission

    HORIZON-IA, Empowering walking, cycling and micro-mobility for cancer prevention and cleaner, healthier and better-connected cities, 101270042, €267.9k, 2026–2029, 29 Apr 2026

  • European Commission

    HORIZON-RIA, Offering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study., 101155975, €597.5k, 2025–2029, 5 Dec 2024

  • European Commission

    HORIZON-RIA, IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION: AN INTEGRATED PLATFORM TO PROMOTE BEHAVIOURAL CHANGE, 101136840, €812k, 2023–2028, 11 Dec 2023

Sources: cordis.europa.eu